Involvement of intracellular ATP in cytotoxicity of topoisomerase II-targetting antitumor drugs.
The effect of the ATP pool on the cytotoxic action of teniposide (VM-26) has been studied in mouse leukemia cells (L1210). L1210 cells in tissue culture were treated with VM-26 (10 microM) in the presence of DNP, an uncoupler of oxidative phosphorylation. The simultaneous treatment of DNP (1 mM) increased cell survival 100-200 fold. Pre- or post-treatment with DNP had little effect on cell survival. Other uncouplers and inhibitors of ATP synthesis had effects similar to DNP. The interference of DNP with the cytotoxic action of VM-26 was also seen with another topoisomerase II-targetting drug, m-AMSA, but not with the topoisomerase I-targetting drug camptothecin. Studies using either purified topoisomerase II or cultured mammalian cells had shown that DNP had little effect on the amount of cleavable complexes induced by VM-26. We propose that an ATP requiring process(es) which occurs subsequent to the formation of the cleavable complexes is involved in the cytotoxic action of topoisomerase II-targetting drugs.
Kupfer
G
G
Bodley
A L
AL
Liu
L F
LF
D000255:Adenosine Triphosphate / Q000378:metabolism*; D002166:Camptothecin / Q000633:toxicity; D002470:Cell Survival / Q000187:drug effects; D002471:Cell Transformation, Neoplastic; D004140:Dinitrophenols / Q000494:pharmacology; D006367:HeLa Cells / Q000201:enzymology; D006801:Humans; D007700:Kinetics; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D013539:Simian virus 40 / Q000235:genetics; D013713:Teniposide / Q000633:toxicity*; D059005:Topoisomerase II Inhibitors
D004140:Dinitrophenols; D059005:Topoisomerase II Inhibitors; D000255:Adenosine Triphosphate; D013713:Teniposide; D011034:Podophyllotoxin; D002166:Camptothecin